Related references
Note: Only part of the references are listed.Platelet phosphatidylserine is the critical mediator of thrombosis in heparin-induced thrombocytopenia
Jan Zlamal et al.
HAEMATOLOGICA (2023)
A Multicenter Retrospective Evaluation of Direct Oral Anticoagulants for the Treatment of Heparin-Induced Thrombocytopenia
Kyle Davis et al.
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2022)
Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia
Christine S. M. Lee et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
Human and mouse PAR4 are functionally distinct receptors: Studies in novel humanized mice
Stephanie A. Renna et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2022)
G protein-coupled receptor kinase 5 regulates thrombin signaling in platelets via PAR-1
Kate Downes et al.
BLOOD ADVANCES (2022)
Current status of diagnosis and treatment of heparin-induced thrombocytopenia (HIT)
Jose A. Paramo et al.
MEDICINA CLINICA (2022)
Characteristics of VITT antibodies in patients vaccinated with Ad26.COV2.S
Angela Huynh et al.
Blood Advances (2022)
GRK2 regulates ADP signaling in platelets via P2Y1 and P2Y12
Xuefei Zhao et al.
BLOOD ADVANCES (2022)
Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis
Layla Van Doren et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)
Platelet Activation Mechanisms and Consequences of Immune Thrombocytopenia
Siyu Sun et al.
CELLS (2021)
The use of IV immunoglobulin in the treatment of vaccine-induced immune thrombotic thrombocytopenia
Guenalp Uzun et al.
BLOOD (2021)
Complement mediates binding and procoagulant effects of ultralarge HIT immune complexes
Sanjay Khandelwal et al.
BLOOD (2021)
Anti-Platelet Factor 4 Antibodies Causing VITT do not Cross-React with SARS-CoV-2 Spike Protein
Andreas Greinacher et al.
BLOOD (2021)
Novel venous thromboembolism mouse model to evaluate the role of complete and partial factor XIII deficiency in pulmonary embolism risk
Sravya Kattula et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Mechanical Characterization of Thrombi Retrieved With Endovascular Thrombectomy in Patients With Acute Ischemic Stroke
Nikki Boodt et al.
STROKE (2021)
Clinical Characteristics and Pharmacological Management of COVID-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia With Cerebral Venous Sinus Thrombosis A Review
John G. Rizk et al.
JAMA CARDIOLOGY (2021)
Inhibition of NADPH oxidase blocks NETosis and reduces thrombosis in heparin-induced thrombocytopenia
Halina H. L. Leung et al.
BLOOD ADVANCES (2021)
Apoptosis signal-regulating kinase 1 regulates immune-mediated thrombocytopenia, thrombosis, and systemic shock
Pravin Patel et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia
Jose Perdomo et al.
NATURE COMMUNICATIONS (2019)
EULAR recommendations for the management of antiphospholipid syndrome in adults
Maria G. Tektonidou et al.
ANNALS OF THE RHEUMATIC DISEASES (2019)
Platelets release pathogenic serotonin and return to circulation after immune complex-mediated sequestration
Nathalie Cloutier et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
A function-blocking PAR4 antibody is markedly antithrombotic in the face of a hyperreactive PAR4 variant
Shauna L. French et al.
BLOOD ADVANCES (2018)
Neutrophil accumulation and NET release contribute to thrombosis in HIT
Kandace Gollomp et al.
JCI INSIGHT (2018)
Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis
Sarah N. Lauder et al.
SCIENCE SIGNALING (2017)
Networks of enzymatically oxidized membrane lipids support calcium-dependent coagulation factor binding to maintain hemostasis
Sarah N. Lauder et al.
SCIENCE SIGNALING (2017)
IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia
Anand Padmanabhan et al.
CHEST (2017)
Clinical outcomes in a cohort of patients with heparin-induced thrombocytopenia
David J. Kuter et al.
AMERICAN JOURNAL OF HEMATOLOGY (2017)
Platelet transactivation by monocytes promotes thrombosis in heparin-induced thrombocytopenia
Valerie Tutwiler et al.
BLOOD (2016)
Anti-miR-148a regulates platelet FcγRIIA signaling and decreases thrombosis in vivo in mice
Yuhang Zhou et al.
BLOOD (2015)
Platelet 12-LOX is essential for FcγRIIa-mediated platelet activation
Jennifer Yeung et al.
BLOOD (2014)
PRT-060318, a novel Syk inhibitor, prevents heparin-induced thrombocytopenia and thrombosis in a transgenic mouse model
Michael P. Reilly et al.
BLOOD (2011)
CalDAG-GEFI deficiency protects mice in a novel model of FcγRIIA-mediated thrombosis and thrombocytopenia
Moritz Stolla et al.
BLOOD (2011)
Phospholipid-esterified Eicosanoids Are Generated in Agonist-activated Human Platelets and Enhance Tissue Factor-dependent Thrombin Generation
Christopher P. Thomas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Risk Factors for Major Bleeding in Patients With Heparin-induced Thrombocytopenia Treated With Argatroban: A Retrospective Study
Marcie J. Hursting et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2008)
Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model
M. P. Reilly et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia
CH Dang et al.
PHARMACOTHERAPY (2006)
International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)
S Miyakis et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Venous and arterial thrombosis following administration of intravenous immunoglobulins
D Paran et al.
BLOOD COAGULATION & FIBRINOLYSIS (2005)
Effect of fondaparinux on platelet activation in the presence of heparin-dependent antibodies: a blinded comparative multicenter study with unfractionated heparin
P Savi et al.
BLOOD (2005)
New laboratory test in flow cytometry for the combined analysis of serologic and cellular parameters in the diagnosis of heparin-induced thrombocytopenia
G Gobbi et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2004)
Impaired hemostasis and protection against thrombosis in protease-activated receptor 4-deficient mice is due to lack of thrombin signaling in platelets
JR Hamilton et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2004)
Platelet 12-lipoxygenase activation via glycoprotein VI - Involvement of multiple signaling pathways in agonist control of H(P)ETE synthesis
MJ Coffey et al.
CIRCULATION RESEARCH (2004)
Role of the Fcγ receptor IIA polymorphism in the antiphospholipid syndrome -: an international meta-analysis
FB Karassa et al.
ARTHRITIS AND RHEUMATISM (2003)
Simultaneous engagement of thrombin and FcγRIIA receptors results in platelets expressing high levels of procoagulant proteins
P Batar et al.
JOURNAL OF LABORATORY AND CLINICAL MEDICINE (2001)
Role of thrombin signalling in platelets in haemostasis and thrombosis
GR Sambrano et al.
NATURE (2001)
A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia - Formation of leukocyte-platelet aggregates
M Khairy et al.
THROMBOSIS AND HAEMOSTASIS (2001)
Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies
GM Arepally et al.
BLOOD (2000)
Share Paper
